Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 8Unknown 7Completed 4Active not recruiting 4Not yet recruiting 3

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Myeloid 3Lymphoid 2

Conditions

Breast Neoplasms 471Neoplasms 328Colorectal Neoplasms 235Carcinoma, Non-Small-Cell Lung 234Lung Neoplasms 200Prostatic Neoplasms 179Carcinoma, Hepatocellular 174Stomach Neoplasms 138Pancreatic Neoplasms 126Leukemia, Myeloid, Acute 114Uterine Cervical Neoplasms 110Rectal Neoplasms 105Multiple Myeloma 94Recurrence 89Squamous Cell Carcinoma of Head and Neck 84Head and Neck Neoplasms 79Neoplasm Metastasis 76Ovarian Neoplasms 75Brain Neoplasms 71Colonic Neoplasms 68Glioblastoma 67Esophageal Neoplasms 66Triple Negative Breast Neoplasms 65Endometrial Neoplasms 58Precursor Cell Lymphoblastic Leukemia-Lymphoma 56Small Cell Lung Carcinoma 54Disease 54Motor Activity 53Hematologic Neoplasms 53Glioma 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × Lymphohistiocytosis, Hemophagocytic × Clear all
NCT06734624 2024-12-16

The Microbiome in Blood Cancer and HLH

University of Nottingham

Not yet recruiting
750 enrolled
LymphoidMyeloid

Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Lymphohistiocytosis, Hemophagocytic

NCT06131489 2023-11-14

Segmental Resection Combined With DEP Regimen for EBV-HLH Patients With Intestinal Involvement

Beijing Friendship Hospital

Not yet recruiting
20 enrolled
Myeloid

Epstein-Barr Virus Infections, Lymphohistiocytosis, Hemophagocytic

NCT05775705 2023-03-20

L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH

Beijing Friendship Hospital

Phase 3 Not yet recruiting
25 enrolled
LymphoidMyeloid

Lymphoma, Epstein-Barr Virus Infections, Lymphohistiocytosis, Hemophagocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡